What happens physiologically at altitude
Above approximately 2,500 metres, progressive hypoxia triggers a coordinated physiological response:
Erythropoiesis and iron demand
The hypoxia-inducible factor (HIF-1α) pathway upregulates erythropoietin (EPO) production within 2–4 hours of altitude exposure. EPO drives red blood cell (RBC) production — altitude acclimatisation typically increases haemoglobin concentration by 1–3 g/dL over 4–6 weeks.
Each gram of haemoglobin increase requires approximately 3.5 mg of iron. For a 70 kg person increasing haemoglobin from 14 to 16 g/dL, this requires approximately 700 mg additional iron — almost entirely from body iron stores (ferritin).
Altitude trekkers and mountaineers with low ferritin (common in women and endurance athletes) may have inadequate iron stores to support full acclimatisation, limiting haemoglobin response and VO₂max improvement.
Oxidative stress amplification
Altitude exposure substantially increases reactive oxygen species (ROS) production through several mechanisms:
- Hypoxia-reoxygenation cycling (at moderate altitudes with physical activity) activates xanthine oxidase and NADPH oxidase
- UV radiation at altitude is 10–15% higher per 1,000 m — generating skin and systemic oxidative load
- Intense exercise (trekking, mountaineering) adds exercise-induced ROS to hypoxic ROS
The result: altitude significantly depletes glutathione, reduces SOD activity, and increases markers of lipid peroxidation (MDA, TBARS) — the same markers spirulina antioxidant trials reduce.
Acute Mountain Sickness (AMS)
AMS affects 25–50% of people ascending above 2,500 m. Symptoms (headache, nausea, fatigue) result from cerebral oedema and neuroinflammation driven by NF-κB activation and pro-inflammatory cytokines (IL-1β, TNF-α).
Phycocyanin’s NF-κB inhibition and antioxidant scavenging of peroxyl radicals are mechanistically relevant to AMS pathology. No dedicated spirulina-AMS trial exists, but the anti-neuroinflammatory mechanisms established in animal models align with AMS pathophysiology.
Spirulina’s altitude-relevant mechanisms
Iron for erythropoiesis support
For altitude trekkers and mountaineers, beginning spirulina supplementation 4–8 weeks before altitude exposure allows ferritin stores to build. At 10 g/day with vitamin C optimisation, spirulina can contribute 10–25 mg absorbed iron per day — meaningful for building pre-altitude ferritin reserves.
Target pre-altitude ferritin: above 50 ng/mL for women, above 70 ng/mL for men. Women travelling to altitude should check ferritin before departure — low ferritin significantly limits acclimatisation capacity.
Phycocyanin as altitude antioxidant
Phycocyanin directly scavenges peroxyl radicals and activates Nrf2 — upregulating endogenous antioxidant enzymes (SOD, catalase, glutathione peroxidase). At altitude, where endogenous antioxidant capacity is overwhelmed, this external antioxidant support is directly relevant.
Unlike high-dose vitamin C or E (which can blunt hypoxic adaptation signalling), phycocyanobilin’s NADPH oxidase inhibition targets pathological ROS specifically rather than broadly suppressing all oxidant signals. This is an important distinction — adaptation signals (HIF-1α, VEGF) are ROS-dependent and should not be suppressed.
Anti-inflammatory support during acclimatisation
The inflammatory component of altitude exposure (NF-κB, TNF-α, IL-6 elevation) is a major contributor to AMS and exercise fatigue at altitude. Phycocyanin’s NF-κB inhibition provides anti-inflammatory support without blunting the hypoxic erythropoietic response — which operates through the HIF pathway, not NF-κB.
Practical protocol for altitude preparation
- 4–8 weeks before altitude exposure:Begin spirulina 10 g/day with vitamin C for iron accumulation. Check ferritin at baseline and after 4 weeks.
- At altitude: Continue spirulina 5–10 g/day. Phycocyanin effect is the primary benefit during acute exposure — antioxidant and anti-inflammatory support.
- If already iron-deficient (ferritin below 30 ng/mL):Spirulina alone is insufficient for rapid repletion. Use ferrous bisglycinate 25–50 mg elemental iron/day for 6–8 weeks pre-altitude, with spirulina alongside.
- Target phycocyanin dose at altitude:300–500 mg/day phycocyanin from 3–5 g quality spirulina. This aligns with the anti-inflammatory trial range without excessive supplement burden.
Who benefits most
- Pre-menopausal women trekking or climbing:Highest risk of altitude-limiting iron deficiency. Pre-altitude iron building with spirulina and vitamin C is the most impactful application.
- Plant-based athletes at altitude:Combined iron and antioxidant gap versus omnivore athletes — spirulina addresses both.
- People living at altitude (Andean/Himalayan populations, Morocco/Ethiopia):Chronic oxidative stress from altitude combined with potential dietary iron insufficiency makes spirulina a particularly coherent supplement.
- Recreational trekkers above 3,000 m:AMS prevention and acclimatisation support.
What spirulina does not do at altitude
- It does not replace proper acclimatisation protocols (gradual ascent, rest days, the “climb high, sleep low” principle)
- It does not prevent or treat High Altitude Pulmonary Oedema (HAPE) or High Altitude Cerebral Oedema (HACE) — these are medical emergencies
- It does not substitute for acetazolamide in people with history of severe AMS